Colleen Kelly

10.0k total citations · 7 hit papers
112 papers, 5.8k citations indexed

About

Colleen Kelly is a scholar working on Infectious Diseases, Epidemiology and Gastroenterology. According to data from OpenAlex, Colleen Kelly has authored 112 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Infectious Diseases, 53 papers in Epidemiology and 39 papers in Gastroenterology. Recurrent topics in Colleen Kelly's work include Clostridium difficile and Clostridium perfringens research (89 papers), Microscopic Colitis (47 papers) and Gut microbiota and health (36 papers). Colleen Kelly is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (89 papers), Microscopic Colitis (47 papers) and Gut microbiota and health (36 papers). Colleen Kelly collaborates with scholars based in United States, Canada and United Kingdom. Colleen Kelly's co-authors include Lawrence J. Brandt, Monika Fischer, Jessica R. Allegretti, Neha Alang, Alexander Khoruts, Christina M. Surawicz, Neil Stollman, Thomas A. Moore, Olga C. Aroniadis and Mark Mellow and has published in prestigious journals such as Nature, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Colleen Kelly

104 papers receiving 5.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treating Clostridium difficile Infection With Fecal Microbiota Transplantation

2011 734 citations Johan Bakken, Thomas J. Borody et al. Clinical Gastroenterology and Hepatology profile →
Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection

2012 524 citations Lawrence J. Brandt, Olga C. Aroniadis et al. profile →
Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection

2016 453 citations Colleen Kelly, Alexander Khoruts et al. profile →
Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook

2015 437 citations Colleen Kelly, Loren Laine et al. Gastroenterology profile →
ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections

2021 313 citations Colleen Kelly, Monika Fischer et al. profile →
The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications

2019 250 citations Jessica R. Allegretti, Colleen Kelly et al. profile →
AGA Clinical Practice Guideline on Fecal Microbiota–Based Therapies for Select Gastrointestinal Diseases

2024 89 citations Colleen Kelly, Dina Kao et al. Gastroenterology profile →

Peers

Countries citing papers authored by Colleen Kelly

Since Specialization

Citations

This map shows the geographic impact of Colleen Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colleen Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colleen Kelly more than expected).

Fields of papers citing papers by Colleen Kelly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colleen Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colleen Kelly. The network helps show where Colleen Kelly may publish in the future.

Co-authorship network of co-authors of Colleen Kelly

This figure shows the co-authorship network connecting the top 25 collaborators of Colleen Kelly. A scholar is included among the top collaborators of Colleen Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colleen Kelly. Colleen Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparability of Gastrointestinal Microbiome and Bile Acid Profiles in Patients With First or Multiply Recurrent Clostridioides difficile Infection 2025 ·The Journal of Infectious Diseases ·Jessica A. Bryant, Timothy J. Straub, Darrell S. Pardi, (unknown), Colleen Kelly, Meghan Chafee, Stuart H. Cohen, Sahil Khanna, Charles S. Berenson, Jennifer R. Wortman, Matthew Sims, Christopher B. Ford, Mary-Jane Lombardo, Barbara McGovern, Lisa Von Moltke, Colleen S. Kraft, Matthew R. Henn, (unknown)	0
2	DOP005 Long-term efficacy and safety of mirikizumab treatment for Crohn’s Disease: Results from the VIVID-2 open-label extension study 2025 ·Journal of Crohn s and Colitis ·Séverine Vermeire, Bruce E. Sands, G. D’Haens, Tadakazu Hisamatsu, Colleen Kelly, Ning Lü, Nathan Morris, (unknown), Frédérick Durand, Marijana Protić, Rebecca R. Hozak, (unknown), Miguel Regueiro, David Laharie	2
3	Tolerability and Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Inflammatory Bowel Disease 2025 ·Digestive Diseases and Sciences ·(unknown), (unknown), (unknown), Pichamol Jirapinyo, Jessica R. Allegretti, Colleen Kelly	6
4	42 ORAL CAPSULE FMT COMBINED WITH BEZLOTOXUMAB IS A SUCCESSFUL RESCUE PROTOCOL FOLLOWING FAILURE OF FMT ALONE IN TREATMENT OF RECURRENT C. DIFFICILE INFECTION 2024 ·Gastroenterology ·(unknown), (unknown), (unknown), Carolyn Graiziger, (unknown), Colleen Kelly, Alexander Khoruts	0
5	Ileal Signet Ring Adenocarcinoma in Crohn’s Disease: Unanticipated Diagnosis After Surgical Resection of a Symptomatic Stricture 2024 ·Digestive Diseases and Sciences ·(unknown), (unknown), Mark Redston, Matthew J. Hamilton, Colleen Kelly	0
6	Efficacy, Safety, and Cost-effectiveness of Bezlotoxumab in Preventing Recurrent Clostridioides difficile Infection 2023 ·Journal of Clinical Gastroenterology ·Mouhand Mohamed, Chris Ward, Azizullah Beran, Mohamed Abdallah, (unknown), Colleen Kelly	8
7	Integrated efficacy analysis from phase 3 studies of investigational microbiome therapeutic, SER-109, in recurrent Clostridioides difficile infection 2023 ·SHILAP Revista de lepidopterología ·Matthew Sims, Michael Silverman, Thomas Louie, Elaine Wang, (unknown), Mayur Ramesh, Tatiana Bogdanovich, (unknown), David A. Lombardi, Aslı Memişoğlu, Ananya De, (unknown), Christine Lee, Paul Feuerstadt, Darrell S. Pardi, Colleen Kelly, Peter Daley, Godson Oguchi, Barbara McGovern, Lisa Von Moltke	1
8	Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection 2022 ·Clinical Gastroenterology and Hepatology ·Byron P. Vaughn, Monika Fischer, Colleen Kelly, Jessica R. Allegretti, Carolyn Graiziger, (unknown), (unknown), Amanda J. Kabage, Alexander Khoruts	31
9	Cost‐effectiveness analysis of sequential fecal microbiota transplantation for fulminant Clostridioides difficile infection 2021 ·Journal of Gastroenterology and Hepatology ·(unknown), Jinyi Zhu, Thomas R. McCarty, (unknown), Zain Kassam, Colleen Kelly, Monika Fischer, Jessica R. Allegretti	6
10	Monitoring Fecal Microbiota Transplantation Practice in a Rapidly Evolving Health and Regulatory Environment 2020 ·Gastroenterology ·Colleen Kelly, Loren Laine, Gary D. Wu	5
11	Systematic review: the global incidence of faecal microbiota transplantation‐related adverse events from 2000 to 2020 2020 ·Alimentary Pharmacology & Therapeutics ·Cicilia Marcella, Bota Cui, Colleen Kelly, Gianluca Ianiro, Giovanni Cammarota, Faming Zhang	174
12	Long-term Outcomes Following Multiply Recurrent Clostridioides difficile Infection and Fecal Microbiota Transplantation 2020 ·Clinical Gastroenterology and Hepatology ·Ghadeer K. Dawwas, Colleen Brensinger, Ravy K. Vajravelu, Qufei Wu, Colleen Kelly, Loren Laine, Gary D. Wu, James D. Lewis	17
13	Unrecognized pulmonary arterial hypertension in hospitalized patients 2020 ·International journal of cardiac imaging ·(unknown), (unknown), Colleen Kelly, Leslee Willes, Stuart F. Quan, Gregg S. Pressman, (unknown), Sunil Sharma	4
14	Microbiome predictors of dysbiosis and VRE decolonization in patients with recurrent C. difficile infections in a multi-center retrospective study 2019 ·PMC ·Marina Santiago, (unknown), Jessica R. Allegretti, Olga C. Aroniadis, Lawrence J. Brandt, Monika Fischer, Ari Grinspan, Colleen Kelly, Casey D. Morrow, Martín Rodríguez, Majdi Osman, Zain Kassam, Mark Smith, Sonia Timberlake	3
15	Hair Growth in Two Alopecia Patients after Fecal Microbiota Transplant 2017 ·ACG Case Reports Journal ·(unknown), (unknown), Eugene F. Yen, Peter Lio, Colleen Kelly	82
16	Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation 2016 ·mBio ·Christopher Staley, Colleen Kelly, Lawrence J. Brandt, Alexander Khoruts, Michael J. Sadowsky	85
17	Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease 2016 ·Inflammatory Bowel Diseases ·Monika Fischer, Dina Kao, Colleen Kelly, Aishwarya Kuchipudi, Syed‐Mohammed Jafri, Mark Blumenkehl, Douglas K. Rex, Mark Mellow, Nirmal Kaur, Harry Sokol, (unknown), Matthew J. Hamilton, Emmalee Phelps, Brian Sipe, Huiping Xu, Jessica R. Allegretti	134
18	A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents RecurrentClostridium difficileInfection 2016 ·The Journal of Infectious Diseases ·Sahil Khanna, Darrell S. Pardi, Colleen Kelly, Colleen S. Kraft, Tanvi Dhere, Matthew R. Henn, Mary-Jane Lombardo, Marin Vulić, Toshiro K. Ohsumi, Jonathan Winkler, Christina Pindar, Barbara McGovern, Roger J. Pomerantz, John Auniņš, David N. Cook, Elizabeth Hohmann	230
19	Treating Clostridium difficile Infection With Fecal Microbiota Transplantation breakdown → 2011 ·Clinical Gastroenterology and Hepatology ·Johan Bakken, Thomas J. Borody, Lawrence J. Brandt, Joel V. Brill, Daniel C. DeMarco, M. Alaric Franzos, Colleen Kelly, Alexander Khoruts, Thomas Louie, Lawrence Martinelli, Thomas A. Moore, George H. Russell, Christina M. Surawicz	734
20	Streptococcus pneumoniae: Bacteremia in an era of penicillin resistance 2000 ·American Journal of Infection Control ·Edward Castillo, Leland S. Rickman, Stephanie K. Brodine, (unknown), Colleen Kelly	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact